Host cell sumoylation level influences papillomavirus E2 protein stability

Virology

Volumn 387, Issue 1, 2009, Pages 176-183

  Wu, Yu Chieh ^a   Bian, Xue Lin ^a   Heaton, Phillip R ^a   Deyrieux, Adeline F ^a   Wilson, Van G ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

HPV; Post translational modification; Proteasome; SUMO

Indexed keywords

PAPILLOMAVIRUS E2 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; FEMALE; HOST CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IN VITRO STUDY; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN STABILITY; SUMOYLATION;

GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HUMANS; PAPILLOMAVIRIDAE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; SUMO-1 PROTEIN; VIRAL PROTEINS;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 63549116482     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.02.002     Document Type: Article

References (45)

1. Agbor T.A., and Taylor C.T. SUMO, hypoxia and the regulation of metabolism. Biochem. Soc. Trans. 36 3 (2008) 445-448
2. Ahn J.H., Xu Y., Jang W.J., Matunis M.J., and Hayward G.S. Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9. J. Virol. 75 8 (2001) 3859-3872
3. Bae S.H., Jeong J.W., Park J.A., Kim S.H., Bae M.K., Choi S.J., and Kim K.W. Sumoylation increases HIF-1alpha stability and its transcriptional activity. Biochem. Biophys. Res. Commun. 324 1 (2004) 394-400
4. Bellanger S., Demeret C., Goyat S., and Thierry F. Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain. J. Virol. 75 16 (2001) 7244-7251
5. Benanti J.A., Williams D.K., Robinson K.L., Ozer H.L., and Galloway D.A. Induction of extracellular matrix-remodeling genes by the senescence-associated protein APA-1. Mol. Cell. Biol. 22 21 (2002) 7385-7397
6. Bies J., Markus J., and Wolff L. Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity. J. Biol. Chem. 277 11 (2002) 8999-9009
7. Chen A., Wang P.Y., Yang Y.C., Huang Y.H., Yeh J.J., Chou Y.H., Cheng J.T., Hong Y.R., and Li S.S. SUMO regulates the cytoplasmonuclear transport of its target protein Daxx. J. Cell. Biochem. 98 4 (2006) 895-911
8. Chiang C.M., Ustav M., Stenlund A., Ho T.F., Broker T.R., and Chow L.T. Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc. Natl. Acad. Sci. U. S. A. 89 13 (1992) 5799-5803
9. Demeret C., Le Moal M., Yaniv M., and Thierry F. Control of HPV 18 DNA replication by cellular and viral transcription factors. Nucleic Acids Res. 23 23 (1995) 4777-4784
10. Demeret C., Desaintes C., Yaniv M., and Thierry F. Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes. J. Virol. 71 12 (1997) 9343-9349
11. Desterro J.M., Rodriguez M.S., and Hay R.T. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell 2 2 (1998) 233-239
12. Deyrieux A.F., Rosas-Acosta G., Ozbun M.A., and Wilson V.G. Sumoylation dynamics during keratinocyte differentiation. J. Cell Sci. 120 1 (2007) 125-136
13. Donaldson M.M., Boner W., and Morgan I.M. TopBP1 regulates human papillomavirus type 16 E2 interaction with chromatin. J. Virol. 81 8 (2007) 4338-4342
14. Garcia-Alai M.M., Gallo M., Salame M., Wetzler D.E., McBride A.A., Paci M., Cicero D.O., and de Prat-Gay G. Molecular basis for phosphorylation-dependent, PEST-mediated protein turnover. Structure 14 2 (2006) 309-319
15. Gill G. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?. Genes Dev. 18 17 (2004) 2046-2059
16. Hadaschik D., Hinterkeuser K., Oldak M., Pfister H.J., and Smola-Hess S. The Papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. J. Virol. 77 9 (2003) 5253-5265
17. Hay R.T. SUMO: a history of modification. Mol. Cell. 18 1 (2005) 1-12
18. Johnson E.S. Protein modification by SUMO. Annu. Rev. Biochem. 73 (2004) 355-382
19. Klumpp D.J., and Laimins L.A. Differentiation-induced changes in promoter usage for transcripts encoding the human papillomavirus type 31 replication protein E1. Virology 257 1 (1999) 239-246
20. Kovelman R., Bilter G.K., Glezer E., Tsou A.Y., and Barbosa M.S. Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses. J. Virol. 70 11 (1996) 7549-7560
21. Lee K.Y., Broker T.R., and Chow L.T. Transcription factor YY1 represses cell-free replication from human papillomavirus origins. J. Virol. 72 6 (1998) 4911-4917
22. Lin X., Liang M., Liang Y.Y., Brunicardi F.C., and Feng X.H. SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J. Biol. Chem. 278 33 (2003) 31043-31048
23. Longworth M.S., and Laimins L.A. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68 2 (2004) 362-372
24. Mao Y., Desai S.D., and Liu L.F. SUMO-1 conjugation to human DNA topoisomerase II isozymes. J. Biol. Chem. 275 34 (2000) 26066-26073
25. Massimi P., Pim D., Bertoli C., Bouvard V., and Banks L. Interaction between the HPV-16 E2 transcriptional activator and p53. Oncogene 18 54 (1999) 7748-7754
26. Matunis M.J., Coutavas E., and Blobel G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135 6 Pt 1 (1996) 1457-1470
27. McPhillips M.G., Oliveira J.G., Spindler J.E., Mitra R., and McBride A.A. Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J. Virol. 80 19 (2006) 9530-9543
28. Ozbun M.A., and Meyers C. Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology 248 2 (1998) 218-230
29. Penrose K.J., and McBride A.A. Proteasome-mediated degradation of the papillomavirus E2-TA protein is regulated by phosphorylation and can modulate viral genome copy number. J. Virol. 74 13 (2000) 6031-6038
30. Penrose K.J., Garcia-Alai M., de Prat-Gay G., and McBride A.A. Casein Kinase II phosphorylation-induced conformational switch triggers degradation of the papillomavirus E2 protein. J. Biol. Chem. 279 21 (2004) 22430-22439
31. Pichler A., Knipscheer P., Oberhofer E., van Dijk W.J., Korner R., Olsen J.V., Jentsch S., Melchior F., and Sixma T.K. SUMO modification of the ubiquitin-conjugating enzyme E2-25 K. Nat. Struct. Mol. Biol. 12 3 (2005) 264-269
32. Poukka H., Aarnisalo P., Karvonen U., Palvimo J.J., and Janne O.A. Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. J. Biol. Chem. 274 27 (1999) 19441-19446
33. Rangasamy D., Woytek K., Khan S.A., and Wilson V.G. SUMO-1 modification of bovine papillomavirus E1 protein is required for intranuclear accumulation. J. Biol. Chem. 275 48 (2000) 37999-38004
34. Rosas-Acosta G., Langereis M.A., Deyrieux A., and Wilson V.G. Proteins of the PIAS family enhance the sumoylation of the papillomavirus E1 protein. Virology 331 1 (2005) 190-203
35. Rosas-Acosta G., Russell W.K., Deyrieux A., Russell D.H., and Wilson V.G. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol. Cell. Proteomics 4 1 (2005) 56-72
36. Saitoh H., and Hinchey J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275 9 (2000) 6252-6258
37. Steffan J.S., Agrawal N., Pallos J., Rockabrand E., Trotman L.C., Slepko N., Illes K., Lukacsovich T., Zhu Y.Z., Cattaneo E., Pandolfi P.P., Thompson L.M., and Marsh J.L. SUMO modification of Huntingtin and Huntington's disease pathology. Science 304 5667 (2004) 100-104
38. Stevenson M., Hudson L.C., Burns J.E., Stewart R.L., Wells M., and Maitland N.J. Inverse relationship between the expression of the human papillomavirus type 16 transcription factor E2 and virus DNA copy number during the progression of cervical intraepithelial neoplasia. J. Gen. Virol. 81 7 (2000) 1825-1832
39. Stubenrauch F., Colbert A.M., and Laimins L.A. Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions. J. Virol. 72 10 (1998) 8115-8123
40. Tomoiu A., Gravel A., Tanguay R.M., and Flamand L. Functional interaction between human herpesvirus 6 immediate-early 2 protein and ubiquitin-conjugating enzyme 9 in the absence of sumoylation. J. Virol. 80 20 (2006) 10218-10228
41. Wilson V.G., and Heaton P.R. Ubiquitin proteolytic system: focus on SUMO. Expert Rev. Proteomics 5 1 (2008) 121-135
42. Wu Y.-C., Roarke A.A., Bian X.-L., and Wilson V.G. Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs). Virology 378 (2008) 329-338
43. Xirodimas D.P., Chisholm J., Desterro J.M., Lane D.P., and Hay R.T. P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2. FEBS Lett. 528 1-3 (2002) 207-211
44. You J., Croyle J.L., Nishimura A., Ozato K., and Howley P.M. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117 3 (2004) 349-360
45. Yurchenko V., Xue Z., Gama V., Matsuyama S., and Sadofsky M.J. Ku70 is stabilized by increased cellular SUMO. Biochem. Biophys. Res. Commun. 366 1 (2008) 263-268